M/S Matha Pharma vs The State Bank Of India on 16 December, 2024
24. The decisions in Bio Research Pharmaceuticals (supra) and
Paramsivam (supra) only establish that the phrase "as far as possible" in
Section 29 of the RDDB Act does not mean that the provisions of the
Second Schedule to the Income Tax Act need not be followed at all or can
be deviated from at the whims and fancies of the Recovery Officer. In
other words, both decisions only hold that where such provisions are in
tune with the Scheme of the RDDB Act, they must be followed without
departure.